Navigation Links
David H. Murdock Research Institute Taps Waters for Laboratory Technology

Strategic Partnership Provides Advanced Technology for Groundbreaking

Nutrition and Disease Research

KANNAPOLIS, N.C. and MILFORD, Mass., Oct. 15 /PRNewswire-FirstCall/ -- The David H. Murdock Research Institute (DHMRI), located at the North Carolina Research Campus in Kannapolis, NC, and Waters Corporation (NYSE: WAT) announced today that Waters(R) has been selected as the institute's primary supplier of analytical science solutions, including mass spectrometers, liquid chromatographs and associated scientific data management software.

"We selected Waters as a partner based on their breakthrough technologies and hands-on approach to customer service. The equipment that we've purchased from Waters is recognized as the most sophisticated laboratory equipment available," said David H. Murdock, DHMRI founder. "This large purchase continues the momentum we're building as a cutting-edge research facility sought after by some of the nation's brightest scientists, and positions us well for the future."

The new laboratory instrumentation will enable DHMRI's research programs in the areas of nutrition science and disease prevention and provide state-of the-art capabilities in proteomics research and metabolic profiling, among other key application areas

"Our respective organizations have a similar focus on pushing the limits of scientific discovery and productivity, as well as collaboration," said Art Caputo, Executive Vice President and President of the Waters Division. "As with all our partners, we are pleased to be working closely with DHMRI to help make scientific discovery at the facility possible."

Among the new mass spectrometers purchased by DHMRI are a number of Waters(R) SYNAPT(TM) High Definition Mass Spectrometers -- the first commercially-available mass spectrometer with the ability to analyze ions by their size, shape and charge in addition to mass -- as well as the Waters Quattro Premier(TM) XE and ACQUITY(R) SQD systems. DHMRI also purchased several ACQUITY UltraPerformance liquid chromatography (UPLC(R)) systems as their preferred inlet to the Institute's mass spectrometers.

About the David H. Murdock Research Institute

The David H. Murdock Research Institute was established as a public charity to support groundbreaking research at the North Carolina Research Campus. Funded through a private grant by David H. Murdock, DHMRI will host the world's top talent and resources - and promote a level of scientific collaboration never before possible. DHMRI is the first of its kind, housing a unique collection of state-of-the-art instrumentation in one central location.

For more information visit

About Waters Corporation

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

For more information visit

Waters, ACQUITY, UPLC, Synapt, and Quattro Premier XE are trademarks of Waters Corporation.


Waters Corporation:

Brian J. Murphy



Phyllis Beaver


SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
5. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. Immunosyn Corporation Names G. David Criner as CFO
8. Pasteuria Bioscience Taps New CEO David N. Duncan
9. David Mott Appointed Non Executive Director at Shire
10. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
11. Transgenomic Appoints David Pauluzzi to Board of Directors
Post Your Comments:
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... IN (PRWEB) , ... November 25, 2015 , ... ... (AMA) and the Organization of Black Aerospace Professionals (OPBAP) has been formalized with ... and other AMA team leaders met with OPBAP leaders Capt. Karl Minter and ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
Breaking Biology Technology:
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):